Baker Brothers Advisors - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 39 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$36,577,000
-4.6%
29,174,0000.0%0.21%
-5.5%
Q1 2022$38,359,000
-10.2%
29,174,0000.0%0.22%
+5.8%
Q4 2021$42,695,000
-1.1%
29,174,0000.0%0.21%
+9.5%
Q3 2021$43,167,000
+12.2%
29,174,0000.0%0.19%
+12.4%
Q2 2021$38,479,000
+221.5%
29,174,000
+218.0%
0.17%
+225.0%
Q1 2021$11,970,0009,174,0000.05%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 88,657,000$148,264,0002.95%
DeepCurrents Investment Group LLC 45,997,000$76,672,0002.94%
TENOR CAPITAL MANAGEMENT Co., L.P. 38,394,000$64,158,0001.47%
WOLVERINE ASSET MANAGEMENT LLC 71,012,000$118,356,0001.28%
Opti Capital Management, LP 3,000,000$5,013,0000.46%
MIZUHO SECURITIES USA LLC 1,663,000$2,766,0000.38%
Verition Fund Management LLC 25,954,000$21,680,6590.24%
Aequim Alternative Investments LP 5,000,000$8,345,0000.24%
PALISADE CAPITAL MANAGEMENT, LP 3,831,000$6,522,0000.18%
LORD, ABBETT & CO. LLC 23,424,000$39,095,0000.14%
View complete list of SAREPTA THERAPEUTICS INC shareholders